Hydrogel-Based Strategies for Intervertebral Disc Regeneration: Advances, Challenges and Clinical Prospects
Year: 2024
Type: article
Abstract: Millions of people worldwide suffer from low back pain and disability associated with intervertebral disc (IVD) degeneration. IVD degeneration is highly correlated with aging, as the nucleus pulposus (NP) dehydrates and the annulus fibrosus (AF) fissures form, which often results in intervertebral disc herniation or disc space collapse and related clinical symptoms. Currently available options for treating intervertebral disc degeneration are symptoms control with therapy modalities, and/or medication, and/or surgical resection of the IVD with or without spinal fusion. As such, there is an urgent clinical demand for more effective disease-modifying treatments for this ubiquitous disorder, rather than the current paradigms focused only on symptom control. Hydrogels are unique biomaterials that have a variety of distinctive qualities, including (but not limited to) biocompatibility, highly adjustable mechanical characteristics, and most importantly, the capacity to absorb and retain water in a manner like that of native human nucleus pulposus tissue. In recent years, various hydrogels have been investigated in vitro and in vivo for the repair of intervertebral discs, some of which are ready for clinical testing. In this review, we summarize the latest findings and developments in the application of hydrogel technology for the repair and regeneration of intervertebral discs.
Source: Gels
DOI: 10.3390/gels10010062
Institutions: Central Michigan University, University of Connecticut
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,955
Funders: National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Biomedical Imaging and Bioengineering, Congressionally Directed Medical Research Programs, U.S. Army Medical Research Acquisition Activity
Awards: G138045179, G1638097314, G1684984659, G2106824347, Biodegradable Matrices with Structural and Physical Cues for Interface Engineering, Biodegradable Matrices for Bone Healing, G3458581170, Ionically Conductive Polymeric Biomaterials and Grafts for Nerve Regeneration, G5263778377, Engineering Composite Nanofibrous Scaffolds for Repairing Segmental Bone Defect, G5691433526, G65494691, G785546917, G7937456880, Engineered Matrices with Electrical and Chemical Stimulation for Peripheral Nerve Repair, G8316532672, Targeting PHLPP to treat interval disc degeneration using surgical and drug delivery methods, Polysaccharide putty formulations for tissue regeneration
OpenAlex ID: W4390876595
